| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |